Logo image of TCTM

TCTM KIDS IT EDUCATION INC (TCTM) Stock Fundamental Analysis

NASDAQ:TCTM - Nasdaq - US8761082002 - ADR - Currency: USD

0.4733  +0.04 (+8.43%)

After market: 0.4519 -0.02 (-4.52%)

Fundamental Rating

2

Taking everything into account, TCTM scores 2 out of 10 in our fundamental rating. TCTM was compared to 71 industry peers in the Diversified Consumer Services industry. TCTM may be in some trouble as it scores bad on both profitability and health. TCTM has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year TCTM was profitable.
In multiple years TCTM reported negative net income over the last 5 years.
TCTM had negative operating cash flow in 4 of the past 5 years.
TCTM Yearly Net Income VS EBIT VS OCF VS FCFTCTM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -500M -1B

1.2 Ratios

TCTM has a Return On Assets (1.32%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA 1.32%
ROE N/A
ROIC N/A
ROA(3y)-7.26%
ROA(5y)-20.43%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
TCTM Yearly ROA, ROE, ROICTCTM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200 -200

1.3 Margins

Looking at the Profit Margin, with a value of 0.65%, TCTM is in line with its industry, outperforming 51.56% of the companies in the same industry.
TCTM has a Operating Margin (0.98%) which is in line with its industry peers.
TCTM has a Gross Margin (45.40%) which is comparable to the rest of the industry.
TCTM's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 0.98%
PM (TTM) 0.65%
GM 45.4%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.22%
GM growth 5Y-4.09%
TCTM Yearly Profit, Operating, Gross MarginsTCTM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40 -40 60

More info and screens

1

2. Health

2.1 Basic Checks

TCTM does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, TCTM has less shares outstanding
Compared to 5 years ago, TCTM has more shares outstanding
There is no outstanding debt for TCTM. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
TCTM Yearly Shares OutstandingTCTM Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M
TCTM Yearly Total Debt VS Total AssetsTCTM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B 2B 2.5B

2.2 Solvency

TCTM has an Altman-Z score of -6.10. This is a bad value and indicates that TCTM is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -6.10, TCTM is not doing good in the industry: 79.69% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -6.1
ROIC/WACCN/A
WACC8.78%
TCTM Yearly LT Debt VS Equity VS FCFTCTM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1B -1B

2.3 Liquidity

TCTM has a Current Ratio of 0.12. This is a bad value and indicates that TCTM is not financially healthy enough and could expect problems in meeting its short term obligations.
TCTM has a Current ratio of 0.12. This is amonst the worse of the industry: TCTM underperforms 98.44% of its industry peers.
A Quick Ratio of 0.12 indicates that TCTM may have some problems paying its short term obligations.
With a Quick ratio value of 0.12, TCTM is not doing good in the industry: 98.44% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.12
Quick Ratio 0.12
TCTM Yearly Current Assets VS Current LiabilitesTCTM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B 2B 2.5B

More info and screens

0

3. Growth

3.1 Past

TCTM shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -88.97%.
The Revenue for TCTM has decreased by -44.28% in the past year. This is quite bad
Measured over the past years, TCTM shows a decrease in Revenue. The Revenue has been decreasing by -7.99% on average per year.
EPS 1Y (TTM)-88.97%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1853.85%
Revenue 1Y (TTM)-44.28%
Revenue growth 3Y-10.18%
Revenue growth 5Y-7.99%
Sales Q2Q%10.84%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y138.22%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year15.17%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
TCTM Yearly Revenue VS EstimatesTCTM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B
TCTM Yearly EPS VS EstimatesTCTM Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 15

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 4.30, the valuation of TCTM can be described as very cheap.
Compared to the rest of the industry, the Price/Earnings ratio of TCTM indicates a rather cheap valuation: TCTM is cheaper than 93.75% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of TCTM to the average of the S&P500 Index (29.36), we can say TCTM is valued rather cheaply.
With a Price/Forward Earnings ratio of 0.18, the valuation of TCTM can be described as very cheap.
TCTM's Price/Forward Earnings ratio is rather cheap when compared to the industry. TCTM is cheaper than 100.00% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.65. TCTM is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 4.3
Fwd PE 0.18
TCTM Price Earnings VS Forward Price EarningsTCTM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -0.86
TCTM Per share dataTCTM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.03
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

TCTM does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

TCTM KIDS IT EDUCATION INC

NASDAQ:TCTM (2/26/2025, 7:27:09 PM)

After market: 0.4519 -0.02 (-4.52%)

0.4733

+0.04 (+8.43%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)08-28 2024-08-28
Earnings (Next)N/A N/A
Inst Owners4.55%
Inst Owner ChangeN/A
Ins Owners0.69%
Ins Owner ChangeN/A
Market Cap4.71M
Analysts82.86
Price TargetN/A
Short Float %53.66%
Short Ratio0.03
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 4.3
Fwd PE 0.18
P/S 0.02
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA -0.86
EPS(TTM)0.11
EY23.24%
EPS(NY)2.67
Fwd EY564.22%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS19.05
BVpS-18.44
TBVpS-19.19
PEG (NY)0.03
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.32%
ROE N/A
ROCE -1.12%
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 0.98%
PM (TTM) 0.65%
GM 45.4%
FCFM N/A
ROA(3y)-7.26%
ROA(5y)-20.43%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.22%
GM growth 5Y-4.09%
F-ScoreN/A
Asset Turnover2.04
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 0.18
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.12
Quick Ratio 0.12
Altman-Z -6.1
F-ScoreN/A
WACC8.78%
ROIC/WACCN/A
Cap/Depr(3y)56.45%
Cap/Depr(5y)59.38%
Cap/Sales(3y)2.31%
Cap/Sales(5y)3.8%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-88.97%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1853.85%
EPS Next Y138.22%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-44.28%
Revenue growth 3Y-10.18%
Revenue growth 5Y-7.99%
Sales Q2Q%10.84%
Revenue Next Year15.17%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-85.54%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-131.74%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-332.49%
OCF growth 3YN/A
OCF growth 5YN/A